C79.11 — Secondary malignant neoplasm of bladder
C79.11 is a billable, specific ICD-10-CM code for secondary malignant neoplasm of bladder. It is valid for submission on a claim.
Excludes2 — not included here, but may coexist
The excluded condition is not part of this code, but a patient can have both. You may code both.
- lymph node metastases (C77.0)
Risk adjustment
C79.11 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C79.11 is named in 44 Medicare coverage policies — 44 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A54472Billing and Coding: MolDX: FDA-Approved KRAS Tests
- A54498Billing and Coding: MolDX: FDA-Approved KRAS Tests
- A54688Billing and Coding: MolDX: FDA-Approved KRAS Tests
Related codes at this level
Codes that share C79.1. If C79.11 is not quite right, the correct code is usually one of these.
Questions about C79.11
- Is C79.11 a billable ICD-10-CM code?
- Yes. C79.11 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C79.11 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80).